Biologics World Korea 2025: The Largest Gathering of Biotech & Biopharma Leaders in East Asia - Driving Breakthroughs in Biologics Manufacturing, Cell & Gene Therapy, and ADC Innovation. Join Global Experts from Biopharma, CMOs, CDMOs, Regulators, and Academia to Shape the Future of Innovation and Collaboration.
Key Themes & Topics
What to Expect at the Biologics World Korea 2025

Attendees
Join over 600 professionals at Biologics World Korea 2025! This is your chance to connect with key industry players, expand your network, and engage in high-level discussions that will shape the future of biologics.

Companies
Meet 120 leading companies driving innovation in the biologics sector. Whether you're looking for new partners or exploring the latest breakthroughs, this is the perfect platform to discover what’s next in the industry.

Speakers
Gain exclusive insights from 30 expert speakers who are shaping the future of biologics. Learn from the best in the field as they share cutting-edge knowledge, practical solutions, and emerging trends you can’t afford to miss.
Testimonials

“Thank you for impactful events arranged for Korean attendees and giving us opportunities to have meaningful discussion with customers.”
West Pharmaceutical Services Korea

“This event was very informative and well put together. Bringing stakeholders together to network, share cross learnings and create new partnerships is key and this conference definitely contributed to creating this platform here in Korea.”
International Vaccine Institute

“It was a great opportunity to meet various experts in industry and listen to their insights!”
AstraZeneca

“Very well organized and focused meeting.”
ABL Bio

“Great conference, and I enjoyed it.”
ILIAS Biologics

“Organizers have been working hard to gather good speakers for this meeting and I am very thankful for organizers' efforts”
SL Bigen, Inc.
WHO
Biologics World Korea 2025 brings together industry leaders, researchers, regulatory experts, and business executives from various sectors of the biotechnology and pharmaceutical industries across East Asia. Attendees include representatives from global and regional biopharmaceutical companies, contract research organizations (CROs), contract development and manufacturing organizations (CMOs/CDMOs), as well as academic and government institutions focused on the development, production, and commercialization of biologics, ADCs (Antibody-Drug Conjugates), and cell & gene therapies (CGT).
WHAT
As an umbrella event encompassing three major conferences, Biologics World Korea 2025 serves as a strategic platform that unites innovations and the latest advancements in biotechnology. The event covers:
- Biologics Manufacturing Korea 2025 – Focused on production strategies, cGMP technologies, and process optimization for biologics manufacturing.
- ADC & Bioconjugate East Asia 2025 – Showcasing advancements in the design, development, and manufacturing of ADCs and bioconjugates for precision therapies.
- CGT East Asia 2025 – Highlighting the development and commercialization of cell and gene therapies, including large-scale manufacturing and regulatory trends.
This event features expert panels, keynote speeches, and networking opportunities, facilitating collaboration among key industry players to drive innovation.
WHY
The biopharmaceutical industry in East Asia is experiencing rapid growth, with increasing investments and technological advancements propelling innovation in biologics, ADCs, and cell & gene therapies. Biologics World Korea 2025 is a must-attend event for companies, academics, and regulators to:
- Gain insights into the latest trends in biologics, ADCs, and CGT manufacturing.
- Network with industry leaders to build strategic collaborations and partnerships.
- Understand regulatory pathways to accelerate product approvals and market entry in Asia and globally.
- Access cutting-edge technologies in biopharmaceutical manufacturing, formulation, and distribution.
By bringing together experts from diverse fields, Biologics World Korea 2025 serves as a premier platform to foster growth and innovation in the biotechnology sector across East Asia.
CONTACT
Ana Laxamana, Business Development Manager
m: +65 6983 6132
Charmaine Poh, Business Development Manager
m: +65 6983 6133
Priyanka Lao, Business Development Manager
m: +65 8143 6248
Nathan Grace Niño, Head of Audience Development
m: +65 6983 6134

Share With Your Network
